Hot foot and arm bath effect on Healthy Volunteers

Effect of hot foot and arm bath to measure the changes in spO2 level, peak expiratory flow rate (PEFR) and heart rate variability on Healthy Volunteers

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036720

Enrollment

Registered

2021-09-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hot foot and Arm Bath: Hot foot and Arm Bath each session of 20 minutes for 10 days Control Intervention1: wait listed control group: healthy volunteer can choose to take the treatment

Eligibility

Inclusion criteria

Inclusion criteria: Non smokers spO2 between 95-98 %

Exclusion criteria

Exclusion criteria: Smokers, Interstitial lung disease(ILD), including pulmonary fibrosis Bronchiectasis Asbestosis, Lung cancer or tumors Cardiac disorderâ??s Pulmonary embolism or blood clot on the lung Pneumonia or tuberculosis Pneumothorax. Malignant tumor. Athletes and doing regular exercises Pregnant and lactating womens, Diagnosed cardiovascular disease, renal disease, liver disease, mental disorders, Peripheral vascular disorder, Loss of sensation in the legs Unconscious, Peripheral neuropathy, Ulcer, lesion or allergy The subject has a BMI greater than 31 (based on weight and height)

Design outcomes

Primary

Measure	Time frame
spo2 assesment will be done by using pulse oximeter Timepoint: spo2 assesment will be done at baseline before the intervention, at the end of treatment at 10 day and after the 15 day of completion of the treatment	—

Secondary

Measure	Time frame
Heart rate variables will be assesed by heart rate variability apparatusTimepoint: heart rate variable assesment will be done at baseline before the intervention, at the end of treatment at 10 day and after the 15 day of completion of the treatment ;lung inflation test will be assesed by peak expiratory flowmeterTimepoint: peak expiratory flow rate assesment will be done at baseline before the intervention, at the end of treatment at 10 day and after the 15 day of completion of the treatment	—

Measure

Time frame

Heart rate variables will be assesed by heart rate variability apparatusTimepoint: heart rate variable assesment will be done at baseline before the intervention, at the end of treatment at 10 day and after the 15 day of completion of the treatment ;lung inflation test will be assesed by peak expiratory flowmeterTimepoint: peak expiratory flow rate assesment will be done at baseline before the intervention, at the end of treatment at 10 day and after the 15 day of completion of the treatment

—

Countries

India

Contacts

Public ContactVarsha Vijay Nathani

Sant Hirdaram Medical College of Naturopathy and Yogic Sciences

drpradeep18bnys@gmail.com9823262179

Outcome results